Executive Moves is an occasional feature on ROI-NJ.com describing some of the important personnel changes in the New Jersey business community. Reports are based on news releases, edited for content, clarity and style.
Kristen Allgor, Melinta Therapeutics
Melinta Therapeutics LLC, a commercial-stage company focused on the development and commercialization of novel antibiotics, announced the appointment of Kristen Allgor as chief human resources officer.
In August of this year, Christine Ann Miller, a global pharmaceutical veteran, joined Melinta as CEO, president and member of the board. Under Miller’s leadership, Melinta expects to build upon its existing platform and enhance its world-class antibiotics portfolio with additional products that address therapeutic areas of critical need.
“As we reimagine Melinta’s future, developing a high-performing team culture is essential to realizing our full potential and achieving sustainable growth,” said Miller. “With Kristen’s proven track record of leading global pharmaceutical organizations through change and building high-performing teams, I’m confident she will be a strong catalyst for helping to lead Melinta through this positive transformation.”
Jim Barkdoll, Stealthbits Technologies Inc.
Stealthbits Technologies Inc., a leader in cybersecurity focused on protecting an organization’s sensitive data and the credentials attackers use to steal that data, has appointed Jim Barkdoll as CEO. A data security veteran with a long, successful track record, Barkdoll most recently served as CEO of Titus, an industry leader in the data classification and security market.
To further strengthen Stealthbits’ product, marketing and finance organizations, the company has expanded its leadership team with the addition of Mark Cassetta as general manager, Karyl Parks as chief marketing officer and Sarah Foottit as chief financial officer. These additions will bolster the expertise of Stealthbits’ existing team, which has propelled the company’s aggressive growth trajectory and customer success during a challenging year.
“Businesses worldwide continue to struggle while wasting time, money and focus in deploying and maintaining two or more technology stacks to address data privacy and security needs,” said Barkdoll. “Stealthbits fully recognizes that meeting this challenge requires an identity-centric view into subject data contained within virtually any data repository. I’m excited to join the expanded management team to drive rapid adoption of this fresh approach to data security and privacy.”
Jessica Battaglia, Larken Associates
Larken Associates, a regional leader in commercial and residential real estate building, development and management, announces the hiring of Jessica Battaglia as corporate counsel. Necessitated by the firm’s high leasing velocity across its diverse, multistate portfolio, the hiring of Battaglia will increase efficiency throughout the leasing process and enhance the capabilities of the firm’s in-house real estate brokerage division, Raider Realty.
As corporate counsel, Battaglia will be working closely with Raider Realty to streamline the leasing process for the company’s almost 3-million-square-foot office, industrial, and retail portfolio. Previously utilizing third-party attorneys for legal review of leasing documents, Larken Associates’ addition of Battaglia provides its leasing team with added efficiency throughout all stages of the leasing process.
In her new role, Battaglia will be tasked with conducting legal review of documentation pertaining to commercial tenants and their leases. Additionally, she will review tenant attorney comments and revisions throughout the lease negotiation process. Battaglia will also provide strategic counsel through the interpretation of federal, state, and local mandates and statutes surrounding COVID-19.
Lauren Holman, Fulfill
Fulfill, formerly the FoodBank of Monmouth and Ocean Counties, is proud to announce the appointment of Lauren Holman as board chair, taking the reins from Jeremy Grunin.
“I am honored to lead this fine organization committed to feeding our neighbors at the Jersey Shore during this critical time in history,” Holman said. “I am looking forward to continuing my work with Fulfill President and CEO Kim Guadagno and building on the successes of my predecessor, Jeremy Grunin.”
Board member Ken Marowitz, the vice president of Frank’s Big and Tall Men’s Shop, will now take over Holman’s former position as vice chair. Fulfill also wants to welcome Karen Franklin, the vice president and chief financial officer of Count Basie Center for the Arts, and author Marie Unanue to our board of trustees.
Chris Maloney, Preferred Home Health Care & Nursing Services
Chris Maloney of Rockaway has been promoted to northern New Jersey regional manager for Preferred Home Health Care & Nursing Services, with offices in New Jersey, Pennsylvania and Delaware. As regional manager, Maloney will oversee the operations and employees of the South Orange, Elmwood Park and Jersey City offices of Preferred.
After graduating from Kings College, Pennsylvania, in 2008 with a B.A. in criminal justice and sociology, Maloney worked for four years at Lincare, a national durable medical equipment company. He then worked for several home care companies until he joined Preferred in 2018 as a client services manager where he focused on achieving better client outcomes. Maloney is a member of the NJ Home Care Association.
Chief Operating Officer Jonathan Herman said, “With our growing presence in northern New Jersey, Chris is the ideal candidate to help that area blossom in the years ahead. Congratulations, Chris, and thank you for your continued and dedicated support of our company as we work hard to execute our long-term vision of growing into a regional home health care and medical equipment powerhouse.”
Matthew J. Chanin, Suburban Propane Partners L.P.
Suburban Propane Partners L.P., a nationwide distributor of propane, fuel oil and related products and services, as well as a marketer of natural gas and electricity, announced that, at its regular meeting, the partnership’s board of supervisors unanimously elected Matthew J. Chanin, as its new chairman, effective Jan. 1.
Chanin has served on the partnership’s board of supervisors since November 2012. From 1996 until his retirement in January 2012, he was senior managing director of Prudential Investment Management, a subsidiary of Prudential Financial Inc., after which he continued to provide consulting services to Prudential until December 2016.
Chris Guttman-McCabe, Anterix
Anterix has named Chris Guttman-McCabe as the company’s chief regulatory and communications officer, where he will lead Anterix’s efforts to share its vision of 900 MHz private broadband connectivity for critical infrastructure across all audiences, including regulators and media.
In his previous role as founder and CEO of CGM Advisors LLC, Guttman-McCabe was instrumental in helping Anterix secure a Report and Order from the Federal Communications Commission transitioning the 900 MHz spectrum band to enable broadband deployment. As a result of this landmark order, Anterix is now poised to deliver on the promise of private broadband connectivity for key industries.
Martin Murtland, Visual Lease
Visual Lease, the leader in lease accounting and management software, announced the appointment of Martin Murtland as vice president, product management. In his role, Murtland will drive the expansion of Visual Lease’s product strategy and oversee the delivery of solutions that will enhance customer value and increase the company’s market share.
Murtland joins Visual Lease with more than 20 years of experience in product management roles. Previously, he served as the VP, product management at Sterling, where he led the company’s drug and health screening product strategy and delivery. Prior to this, Murtland served as the senior VP, product and data at PR Newswire (now Cision), where he led e-commerce and analytics product strategy and development. Murtland held various leadership positions at Dow Jones, where he was responsible for the creation of the award-winning solution, Dow Jones Media Relations Manager, which grew his product line at a compound annual growth rate of 26% over 6 years.
Robert O’Brien, Real Endpoints
Real Endpoints, a leading boutique life science consultancy focused on market access, announced it has hired Robert O’Brien as vice president, specialty, to further expand its abilities to gain access and coverage for its clients’ medical innovations.
O’Brien has spent the last 20 years in roles of increasing responsibility at CVS Health, one of the Top 3 integrated insurer-PBM providers. Most recently, he led large teams of clinicians, product development and sales professionals creating, advising on and selling solutions focused on specialty drug management strategies and patient care. O’Brien worked closely with virtually all key plan decisionmakers responsible for drug-coverage policies and specialty pharmacy strategies — a $60 billion business for CVS.
Dr. Pierantonio Russo, Spring Hills
Spring Hills announced it has named Dr. Pierantonio Russo chief medical officer and chief clinical transformation officer of the Population Health Management Program. Russo will oversee the integration of Population Health into Spring Hills’ clinical programs and offer guidance to providers, payers and policymakers on information technology- and artificial intelligence-enabled comprehensive population management, including complex care for high-risk, high cost, high needs patients.
Following two decades of practicing cardiac and heart transplant surgery, first at the Mayo Clinic, Russo assumed executive leadership roles providing expertise in medical informatics, machine learning and predictive modeling applications in health care, value-based insurance and outcome-based contracts, and population medicine. Prior to joining Spring Hills, Russo served as the chief medical officer of HVH/Eversana, a leading provider of AI and ML for health care applications and global commercial services to the life sciences industry. Among other projects, Russo led an initiative with the National Institutes of Health on early predictors and medical cost of several rare diseases.